Replies to post #522709 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Thanks again biosectinvestor, I do agree with you about how quickly NWBio will be able to get DCVax-L regulatory approval and reimbursement approval in Germany. But, as you may know, the EU is comprised of 28 separate member countries, and I am factoring in time for reimbursement approvals for all 28 member EU countries:

The EU countries are: Austria, Belgium, Bulgaria, Croatia, Republic of Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and Sweden.

But again, I would prefer to overestimate, and then be pleasantly surprised to have all of these DCVax-L reimbursement approvals in less than 2 years.